Related Experiment Video
Updated: May 16, 2026

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
Efficacy and safety of ketamine in refractory status epilepticus in children
Anna Rosati1, Manuela L'Erario, Lucrezia Ilvento
1Pediatric Neurology Unit, Children's Hospital A. Meyer, University of Firenze, Florence, Italy.
Objective:
To evaluate the efficacy and safety of ketamine (KE) in the management of refractory convulsive status epilepticus (RSE) in children.
Methods:
In November 2009, we started using KE for treating all children consecutively referred for RSE. Clinical and treatment data were analyzed.
Results:
Between November 2009 and June 2011, 9 children with RSE received IV KE. In 8 patients, SE had persisted for more than 24 hours (super-refractory RSE), with a median of 6 days (mean 8.5 ± 7.5; range 2-26 days). Prior to KE administration, conventional anesthetics were used, including midazolam, thiopental, and propofol in 9, 5, and 4 patients each. Median dose of KE in continuous IV infusion was 40 gamma(microg)/kg/min (mean 36.5 ± 18.6 gamma[microg]/kg/min; range 10-60 gamma[microg]/kg/min). Midazolam was administered add-on to prevent emergence reactions. The use of KE was associated with resolution of RSE in 6 children. None of the patients experienced serious adverse events. Among the 3 individuals who did not respond to KE, 2 were cured by surgical removal of epileptogenic focal cortical dysplasia.
Conclusion:
In this small, open-label, unblinded series with no concurrent control group, KE appears effective and safe in treating RSE in children. Larger, randomized studies are needed to confirm data emerging from this preliminary observation.
Classification Of Evidence:
This study provides Class IV evidence that IV KE can be effective in treating children with RSE (no statistical analysis was done).
Related Concept Videos
Parenteral Anesthetics: Overview
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Electroconvulsive Therapy
Pharmacokinetics in Pediatric Patients: Drug Excretion
